ScholarIQanswers from OpenAlex & ORCID
Daniel F. Heitjan
ResearcherPublications, citations & collaboration network
Daniel F. Heitjan is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Daniel F. Heitjan have?
ScholarIQindexed works
Daniel F. Heitjan has 338 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Daniel F. Heitjan have?
ScholarIQcitation count
Daniel F. Heitjan has 21,554 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Daniel F. Heitjan?
ScholarIQh-index
Daniel F. Heitjan has an h-index of 70 in OpenAlex.
What is the i10-index of Daniel F. Heitjan?
ScholarIQi10-index
Daniel F. Heitjan has an i10-index of 184 in OpenAlex.
What is the ORCID of Daniel F. Heitjan?
ScholarIQorcid
The ORCID for Daniel F. Heitjan is on the source record.
What is the OpenAlex record for Daniel F. Heitjan?
ScholarIQopenalex
The OpenAlex for Daniel F. Heitjan is on the source record.
What are the most-cited papers on Daniel F. Heitjan?
ScholarIQmost cited works
Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure
Eric A. Rose, Annetine C. Gelijns, Alan J. Moskowitz, Daniel F. Heitjan, Lynne Warner Stevenson, Walter P. Dembitsky, James W. Long, Deborah D. Ascheim, Anita R. Tierney, Ronald G. Levitan, John T. Watson, Nuala S. Ronan, Peter A. Shapiro, Ronald M. Lazar, Leslie W. Miller, Lopa Gupta, O.H. Frazier, Patrice Desvigne‐Nickens, Mehmet C. Öz, Victor L. Poirier, Paul Meier
Combined MTOR and autophagy inhibition
Reshma Rangwala, Yunyoung C Chang, Janice Hu, Kenneth M. Algazy, Tracey L. Evans, Leslie A. Fecher, Lynn M. Schuchter, Drew A. Torigian, Jeffrey T Panosian, Andrea B. Troxel, Kay-See Tan, Daniel F. Heitjan, Angela DeMichele, David J. Vaughn, Maryann Redlinger, Abass Alavi, Jonathon Kaiser, Laura Pontiggia, Lisa E. Davis, Peter J. O’Dwyer, Ravi K. Amaravadi
Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma
Reshma Rangwala, Robert D. Leone, Yunyoung C Chang, Leslie A. Fecher, Lynn M. Schuchter, Amy Kramer, Kay-See Tan, Daniel F. Heitjan, Glenda Rodgers, Maryann Gallagher, Shengfu Piao, Andrea B. Troxel, Tracey L. Evans, Angela DeMichele, Katherine L. Nathanson, Peter J. O’Dwyer, Jonathon Kaiser, Laura Pontiggia, Lisa E. Davis, Ravi K. Amaravadi
Phase I Trial of Docetaxel With Estramustine in Androgen-Independent Prostate Cancer
Daniel P. Petrylak, Robert B. MacArthur, John F. O’Connor, Gary Shelton, Timothy Judge, Joshua Balog, Charles Pfaff, Emilia Bagiella, Daniel F. Heitjan, Robert Fine, Nancy Zuech, Ihor S. Sawczuk, Mitchell C. Benson, Carl A. Olsson
Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial
Caryn Lerman, Robert A. Schnoll, Larry W Hawk, Paul M. Cinciripini, Tony P. George, E. Paul Wileyto, Gary E. Swan, Neal L. Benowitz, Daniel F. Heitjan, Rachel F. Tyndale